Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
1.98 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 56.406 | 65.2 | 73.4 | 64.179 | 74.141 | 66.865 | 68.914 | 79.025 | 204.713 | 191.263 | 242.732 | 244.293 | 228.444 | 204.81 | 217.775 | 148.211 | 98.353 | 87.859 | 46.905 | 50.981 | 35.96 |
| Cost of Revenue
| 37.444 | 36.826 | 38.271 | 45.204 | 35.708 | 36.686 | 43.273 | 33.676 | 53.253 | 38.176 | 37.496 | 40.032 | 39.138 | 32.047 | 37.513 | 30.368 | 23.395 | 19.76 | 21.197 | 15.297 | 17.83 |
| Gross Profit
| 18.962 | 28.374 | 35.129 | 18.975 | 38.433 | 30.179 | 25.641 | 45.349 | 151.46 | 153.087 | 205.236 | 204.261 | 189.306 | 172.763 | 180.262 | 117.843 | 74.958 | 68.099 | 25.708 | 35.684 | 18.13 |
| Gross Profit Ratio
| 0.336 | 0.435 | 0.479 | 0.296 | 0.518 | 0.451 | 0.372 | 0.574 | 0.74 | 0.8 | 0.846 | 0.836 | 0.829 | 0.844 | 0.828 | 0.795 | 0.762 | 0.775 | 0.548 | 0.7 | 0.504 |
| Reseach & Development Expenses
| 4.561 | 4.344 | 5.284 | 5.032 | 4.594 | 4.347 | 4.194 | 4.145 | 5.011 | 5.389 | 4.274 | 3.695 | 9.184 | 1.95 | 1.932 | 2.164 | 2.092 | 1.868 | 1.6 | 3.744 | 0.979 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.784 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 41.243 | 39.087 | 40.556 | 31.197 | 33.626 | 38.864 | 35.377 | 38.671 | 37.203 | 30.795 | 28.061 | 33.2 | 25.581 | 25.189 | 24.085 | 23.237 | 41.621 | 20.51 | 15.988 | 16.126 | 15.784 |
| Other Expenses
| 11.288 | 154.057 | 0 | 0.106 | 0.049 | 0.066 | -1.62 | 0.168 | 0.914 | -0.004 | -1.275 | 0.007 | 0.201 | 0.078 | -0.003 | 0.003 | -7.598 | 0.032 | 0.02 | 0.08 | 0.023 |
| Operating Expenses
| 57.092 | 197.488 | 45.84 | 36.229 | 38.22 | 43.211 | 39.571 | 42.816 | 42.214 | 36.184 | 32.335 | 36.895 | 34.765 | 27.139 | 26.017 | 25.401 | 43.713 | 22.378 | 17.588 | 19.87 | 16.763 |
| Operating Income
| -38.13 | -169.114 | -9.512 | -17.254 | 0.213 | -15.417 | -11.614 | -2.161 | 109.246 | 116.903 | 180.701 | 167.366 | 154.541 | 156.873 | 154.245 | 92.442 | 31.245 | 45.721 | 8.12 | 34.816 | 1.286 |
| Operating Income Ratio
| -0.676 | -2.594 | -0.13 | -0.269 | 0.003 | -0.231 | -0.169 | -0.027 | 0.534 | 0.611 | 0.744 | 0.685 | 0.676 | 0.766 | 0.708 | 0.624 | 0.318 | 0.52 | 0.173 | 0.683 | 0.036 |
| Total Other Income Expenses Net
| -8.372 | -6.53 | -7.415 | -3.548 | 655.973 | -5.146 | -1.75 | -7.056 | -13.37 | -3.14 | -5.709 | -0.525 | -6.396 | -5.221 | -7.805 | -2.881 | -16.404 | -7.057 | -7.443 | -7.302 | -7.696 |
| Income Before Tax
| -46.502 | -175.644 | -16.927 | -22.409 | 656.186 | -20.563 | -13.364 | -4.523 | 95.876 | 113.763 | 174.992 | 166.841 | 144.689 | 151.652 | 145.73 | 89.561 | 14.841 | 38.664 | 0.677 | 27.514 | -6.41 |
| Income Before Tax Ratio
| -0.824 | -2.694 | -0.231 | -0.349 | 8.851 | -0.308 | -0.194 | -0.057 | 0.468 | 0.595 | 0.721 | 0.683 | 0.633 | 0.74 | 0.669 | 0.604 | 0.151 | 0.44 | 0.014 | 0.54 | -0.178 |
| Income Tax Expense
| -0.007 | 0.311 | -2.435 | 0.271 | 766.168 | -5.461 | -1.421 | -3.175 | 8.447 | 14.11 | 18.271 | 19.981 | 17.578 | 18.842 | 11.386 | 13.709 | 0.369 | -0.359 | -0.765 | 3.635 | -0.96 |
| Net Income
| -26.145 | -99.038 | -7.585 | -12.078 | -105.959 | -6.462 | -6.541 | -1.348 | 87.429 | 99.653 | 156.721 | 146.86 | 55.83 | 54.274 | 49.075 | 23.247 | 25.209 | 38.95 | 0.207 | 23.389 | -5.391 |
| Net Income Ratio
| -0.464 | -1.519 | -0.103 | -0.188 | -1.429 | -0.097 | -0.095 | -0.017 | 0.427 | 0.521 | 0.646 | 0.601 | 0.244 | 0.265 | 0.225 | 0.157 | 0.256 | 0.443 | 0.004 | 0.459 | -0.15 |
| EPS
| -0.19 | -0.7 | -0.056 | -0.091 | -0.8 | -0.049 | -0.05 | -0.01 | 0.66 | 0.76 | 0.61 | 0.58 | 0.42 | 0.46 | 0.44 | 0.24 | 0.6 | 0.44 | 0.002 | 0.26 | -0.056 |
| EPS Diluted
| 0 | -0.7 | -0.056 | -0.091 | -0.8 | -0.049 | -0.05 | -0.01 | 0.66 | 0.76 | 0.61 | 0.58 | 0.42 | 0.44 | 0.44 | 0.24 | 0.13 | 0.44 | 0.002 | 0.26 | -0.056 |
| EBITDA
| -20.713 | -147.971 | 9.559 | 2.208 | 684.566 | 4.17 | 5.456 | 18.217 | 114.144 | 126.808 | 188.335 | 178.761 | 157.11 | 167.273 | 161.58 | 105.225 | 37.17 | 52.424 | 14.615 | 22.58 | 7.944 |
| EBITDA Ratio
| -0.367 | -2.269 | 0.13 | 0.034 | 9.233 | 0.062 | 0.079 | 0.231 | 0.558 | 0.663 | 0.776 | 0.732 | 0.688 | 0.817 | 0.742 | 0.71 | 0.378 | 0.597 | 0.312 | 0.443 | 0.221 |